Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

BUY
$1.52 - $2.8 $33 - $61
22 New
22 $0
Q4 2022

Feb 02, 2023

SELL
$1.67 - $2.51 $405,090 - $608,848
-242,569 Reduced 93.92%
15,716 $29,000
Q3 2022

Nov 04, 2022

BUY
$1.96 - $2.93 $506,238 - $756,775
258,285 New
258,285 $663,000
Q2 2022

Aug 03, 2022

SELL
$1.73 - $3.09 $2,466 - $4,406
-1,426 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$2.94 - $4.77 $13,988 - $22,695
-4,758 Reduced 76.94%
1,426 $4,000
Q4 2021

Feb 23, 2022

SELL
$4.07 - $5.3 $77,395 - $100,784
-19,016 Reduced 75.46%
6,184 $27,000
Q3 2021

Oct 28, 2021

BUY
$4.7 - $7.24 $394 - $608
84 Added 0.33%
25,200 $182,000
Q2 2021

Aug 12, 2021

BUY
$6.81 - $10.93 $171,039 - $274,517
25,116 New
25,116 $171,000
Q4 2020

Feb 02, 2021

SELL
$4.58 - $7.14 $6,938 - $10,817
-1,515 Closed
0 $0
Q3 2020

Oct 14, 2020

SELL
$4.19 - $6.69 $46,106 - $73,616
-11,004 Reduced 87.9%
1,515 $8,000
Q2 2020

Jul 13, 2020

BUY
$2.97 - $5.22 $23,956 - $42,104
8,066 Added 181.14%
12,519 $65,000
Q1 2020

Apr 29, 2020

SELL
$2.67 - $4.97 $77,929 - $145,059
-29,187 Reduced 86.76%
4,453 $14,000
Q4 2019

Feb 05, 2020

BUY
$2.93 - $4.5 $77,598 - $119,178
26,484 Added 370.1%
33,640 $135,000
Q3 2019

Oct 15, 2019

BUY
$3.08 - $5.76 $21,941 - $41,034
7,124 Added 22262.5%
7,156 $30,000
Q2 2019

Jul 26, 2019

BUY
$3.47 - $6.32 $111 - $202
32 New
32 $0
Q1 2019

Apr 18, 2019

SELL
$5.36 - $7.24 $9,095 - $12,286
-1,697 Closed
0 $0
Q4 2018

Jan 16, 2019

SELL
$4.8 - $11.6 $14,779 - $35,716
-3,079 Reduced 64.47%
1,697 $8,000
Q3 2018

Oct 23, 2018

BUY
$9.05 - $10.95 $43,222 - $52,297
4,776 New
4,776 $46,000
Q1 2018

Apr 26, 2018

SELL
$12.65 - $18.85 $56,026 - $83,486
-4,429 Closed
0 $0
Q4 2017

Jan 10, 2018

SELL
$17.45 - $25.6 $556,463 - $816,358
-31,889 Reduced 87.8%
4,429 $79,000
Q3 2017

Oct 25, 2017

BUY
$18.9 - $28.2 $686,410 - $1.02 Million
36,318
36,318 $911,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.